SSKN
SSKN
NASDAQ · Health Care

Strata Skin Sciences Inc

$0.13
+0.01 (+8.26%)
Financial Highlights (FY 2026)
Revenue
38.87M
Net Income
-7,927,281
Gross Margin
58.2%
Profit Margin
-20.4%
Rev Growth
-5.3%
D/E Ratio
5.28
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 58.2% 58.2% 60.4% 60.4%
Operating Margin -15.3% -13.8% 8.3% 6.6%
Profit Margin -20.4% -19.4% 6.1% 6.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 38.87M 41.04M 4.50M 3.54M
Gross Profit 22.64M 23.91M 2.72M 2.14M
Operating Income -5,950,239 -5,655,523 373.5K 235.6K
Net Income -7,927,281 -7,534,642 275.7K 228.3K
Gross Margin 58.2% 58.2% 60.4% 60.4%
Operating Margin -15.3% -13.8% 8.3% 6.6%
Profit Margin -20.4% -19.4% 6.1% 6.4%
Rev Growth -5.3% -5.3% +8.7% -6.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 324.2K 324.2K 2.50M 2.27M
Total Equity 61.4K 61.4K 2.00M 2.12M
D/E Ratio 5.28 5.28 1.25 1.07
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -730,725 -733,117 439.3K 404.4K
Free Cash Flow 280.3K 178.6K